تقرير
177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer.
العنوان: | 177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer. |
---|---|
المؤلفون: | Perrone E; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany; Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Rome, Italy. elisabetta.perrone01@icatt.it., Ghai K; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany., Eismant A; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany., Konz K; Department of Endocrinology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany., Baum RP; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany. |
المصدر: | Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Jul 05; Vol. 63, pp. 557-562. Date of Electronic Publication: 2024 Jul 05. |
نوع المنشور: | Case Reports; Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2024- : [Uppsala, Sweden] : Medical Journals Sweden AB Original Publication: Stockholm, Sweden : Acta Oncologica, [1987- |
مواضيع طبية MeSH: | Adrenal Gland Neoplasms*/secondary , Adrenal Gland Neoplasms*/radiotherapy , Lutetium*/therapeutic use , Radiopharmaceuticals*/therapeutic use, Aged ; Humans ; Male ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prostate-Specific Antigen ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/pathology ; Radioisotopes/therapeutic use |
المشرفين على المادة: | 0 (Dipeptides) 0 (Heterocyclic Compounds, 1-Ring) 5H0DOZ21UJ (Lutetium) BRH40Y9V1Q (Lutetium-177) 0 (Pluvicto) EC 3.4.21.77 (Prostate-Specific Antigen) 0 (Radioisotopes) 0 (Radiopharmaceuticals) |
تواريخ الأحداث: | Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240713 |
رمز التحديث: | 20240713 |
DOI: | 10.2340/1651-226X.2024.40017 |
PMID: | 38967321 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1651-226X |
---|---|
DOI: | 10.2340/1651-226X.2024.40017 |